HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 454315Generated: October 30, 2026
Potassium Carbonate → (5S)-6-methoxy-4-(2-methyl-1H-indol-5-yloxy)-7-(1-methyl-2-oxopyrrolidin-5-ylmethoxy)quinazoline
https://huagongshe.com/reaction/454315
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Potassium Carbonate | HCID 11430 | — |
| Reactant | (5S)-5-(p-toluenesulphonylmethyl)-1-methyl-2-pyrrolidinone | HCID 57001804 | — |
| Reactant | 7-hydroxy-6-methoxy-4-(2-methyl-1H-indol-5-yloxy)quinazoline | HCID 135763108 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | (5S)-6-methoxy-4-(2-methyl-1H-indol-5-yloxy)-7-(1-methyl-2-oxopyrrolidin-5-ylmethoxy)quinazoline | HCID 57281674 | 33% |
Reaction Steps
To a solution of 7-hydroxy-6-methoxy-4-(2-methyl-1H-indol-5-yloxy)quinazoline (225 mg, 0.7 mmol), (prepared as described in Example 49), in DMF was added powdered potassium carbonate (290 mg, 2.1 mmol) and (5S)-5-(p-toluenesulphonylmethyl)-1-methyl-2-pyrrolidinone (340 mg, 1.2 mmol). The reaction was then heated at 95° C. for 5 hours. The inorganic material was filtered off and the DMF removed by evaporation. The residue was then purified by chromatography eluting from methylene chloride to 12% methanol/88% methylene chloride (+1% ammonium hydroxide). The product was evaporated, triturated with ether and filtered to give (5S)-6-methoxy-4-(2-methyl-1H-indol-5-yloxy)-7-(1-methyl-2-oxopyrrolidin-5-ylmethoxy)quinazoline (100 mg, 33%) as a white solid.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08492560B2 |
|---|
| Source dataset | uspto-grants-2013_07 |
|---|
| ORD ID | ord-38a66723fb84480186985e15b40c255c |
|---|
| Source note | uspto-grants-2013_07 |
|---|